Antiretroviral drug concentrations in semen of HIV-1 infected men

Sexually Transmitted Infections

Volumn 77, Issue 1, 2001, Pages 4-11

  Taylor, S ^a   Pereira, A S ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretrovirals; Drug concentrations; HIV; Pharmacokinetics; Protein binding; Semen

Indexed keywords

AMPRENAVIR; EFAVIRENZ; ELACRIDAR; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISPOSITION; DRUG PROTEIN BINDING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; KIDNEY TUBULE; LIPID SOLUBILITY; MALE; MALE GENITAL SYSTEM; MOUSE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; REVIEW; SEMEN ANALYSIS; SEMINAL PLASMA; SEXUAL TRANSMISSION; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DIFFUSION; EXTRACELLULAR SPACE; GENITALIA, MALE; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY; MALE; MODELS, BIOLOGICAL; PLACENTA; SEMEN;

EID: 0035130607     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.77.1.4     Document Type: Review

References (66)

1. Sexual transmission of HIV
2. Sexual transmission of HIV: Infectiousness and prevention
3. HIV-1 in semen: An isolated virus reservoir
4. Human immuno-deficiency virus type 1 populations in blood and semen
5. Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma
6. Detection and quantification of HIV-1 in semen: Identification of a subpopulation of men at high potential risk of viral sexual transmission
7. Effect of antiviral treatment on the shedding of HIV-1 in semen
8. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
9. Multi-drug resistant HIV-1 in semen: Treatment of concurrent gonorrhoea may limit the spread of drug resistant virus
10. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission
11. Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: Differences in semen and blood HIV-I RNA and proviral DNA
12. HIV-1 drug resistance in newly infected individuals
13. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
14. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
15. Passage of chemicals into human and animal semen: Mechanisms and significance
16. Drugs in semen
17. Physiology of the prostate
18. Factors contributing to variability in drug pharmacokinetics. II. Drug distribution
19. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents
20. Antiretroviral drug concentrations in semen
21. Antiretroviraldrug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1
22. Pharmacokinefics of quinolone derivatives in the prostate
23. Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex
24. Free drug measurements: Methodology and clinical significance
25. Free drug monitoring
26. Intravascular distribution of zidovudine: Role of plasma proteins and whole blood components
27. The effect of increasing alpha 1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitots
28. The maternal-fetal transfer of lamivudine in the ex vivo human placenta
29. Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours
30. Interaction of 3′-azido-3′-deoxythymidine with organic ion transport in rat renal basolateral membrane vesicles
31. Effect of 3′-azido-3′-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles
32. Interaction of 3′-azido-3′-deoxthymidine with the organic base transporter in a cultured renal epithelium
33. Effects of probenecid and cimetidine on the renal excretion of 3′-azido-3′-deoxythymidine in rats
34. Renal secretion of 3′-azido-3′-deoxythymidine by the rat
35. The functional role of p-glycoprotein in the blood-brain barrier
36. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter
37. Saquinavir, an HIV protease inhibitor, is transported by p-glycoprotein
38. Cellular localization of p-glycoprotein in brain versus gonadal capillaries
39. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
40. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor
41. Saturation kinetics, specificity and NBMPR sensitivity of thymidine entry into the central nervous system
42. The passage of azidodeoxythymidine into and within the central nervous system: Does it follow the parent compound, thymidine?
43. Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat
44. Specificity and sodium dependence of the active nucleoside transport system in choroid plexus
45. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood brain barrier via a probenecid-sensifive transport system
46. Distributed model analysis of 3′-azido-3prime;-deoxythymidine and 2′,3′-dideoxyinosine distribution in brain tissue and cerebrospinal fluid
47. Nucleoside analogues achieve high concentrations in seminal plasma: Relationship between drug concentration and virus burden
48. Semen and serum pharmacokinetics of zidovudine ans zidovudine-glucuronidein men with HIV-1 infection
49. Concentrations of nevirapine, lamivudine and stavudine in semen of HIV1 infected men
50. The concentrations of D4T, 3TC, nelfinavir, and saquinavir in plasma cerebrospinal fluid, and semen
51. 24h ratios
52. Antiretroviral drug concentrations in semen of HIV-1 infected men: Differential penetration of indinavir, ritonavir and saquinavir
53. Enhanced penetration of indinavir in cerebrospinal fluid after addition of low dose ritonavir
54. Poor penetration of the male genital tract by HIV-1 protease inhibitors
55. Analysis of amprenavir, 3TC/AZT in blood and seminal plasma: Penetration of amprenavir into the male genital tract
56. Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus
57. Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-l-infected patients
58. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
59. Indinavir-based treatment of HIV-1 infected patients: Efficacy in the central nervous system
60. A population model-based approach for determining lamivudine cerebrospinal fluid penetration in HIV-infected adults
61. The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1
62. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen
63. Recovery of human immunodeficiency virus type 1 from semen: Minimal impact of stage of infection and current antiviral chemotherapy